A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression

NCT07289048 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology